News & Publications
The latest news and publications about Merkel cell carcinoma and merkelcell.org.
Drs. Jaimes and Nghiem publish a new chapter on Merkel cell carcinoma in the 7th edition of Fitpatrick's Dermatology in General Medicine textbook.
Read more →Merkel cell carcinoma (MCC) is a rare cutaneous malignancy. Because of the absence of randomized studies, the real benefit of adjuvant radiation therapy in MCC is unclear. The aim of this study was to better define the role of adjuvant radiation therapy in the management of MCC.
Read more →The June 2006 issue of the Archives of Dermatology features several articles on Merkel cell carcinoma discussing the role of sentinal lymph node biopsy in prognosis and improved therapy, the importance of adjuvant radiation and an editorial highlighting the management and treatment of MCC. This stud...
Read more →The June 2006 issue of the Archives of Dermatology features several articles on Merkel cell carcinoma discussing the role of sentinal lymph node biopsy in prognosis and improved therapy, the importance of adjuvant radiation and this editorial highlighting the management and treatment of MCC.
Read more →The June 2006 issue of the Archives of Dermatology features several articles on Merkel cell carcinoma discussing the role of sentinal lymph node biopsy in prognosis and improved therapy, the importance of adjuvant radiation and an editorial highlighting the management and treatment of MCC. This stud...
Read more →Purpose: The effectiveness of synchronous carboplatin, etoposide, and radiation therapy was prospectively assessed in a group of patients with high-risk Merkel cell carcinoma (MCC) of the skin. Patients and Methods: Patients were eligible if they had disease localized to the primary site and nodes, ...
Read more →With a mortality rate of roughly 25%, Merkel cell carcinoma (MCC) is significantly more dangerous than melanoma (roughly 15% mortality). Although precise numbers do not exist, its incidence of approximately 400 cases per year in the United States is likely to be on the rise. Factors that are likely ...
Read more →Merkel cell carcinoma is a rare and potentially aggressive cancer of the skin. Cumulative data from small retrospective series have supported treatment by wide excision and adjuvant radiotherapy. However, wide excision may be difficult to perform in patients with tumors of the head and neck or in ol...
Read more →Background: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer. Objective: We sought to describe primary MCC incidence trends, epidemiology, and predictors of survival. Methods The population covered by the Surveillance, Epidemiology, and End Results Program was analyzed as a prospective ...
Read more →Merkel cell carcinoma (MCC) is a rare skin cancer that occurs more frequently after organ transplantation or B-cell malignancy, conditions of suppressed or disordered immunity. To assess further whether immune suppression increases MCC risk, we studied its occurrence in a cohort of 309365 individual...
Read more →